TetR-Expressing Cell Line for Adenoviral Vector Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The development of adenoviral vectors for genetic vaccines faces challenges due to high transgene expression in packaging cell lines, which interferes with virus replication, leading to reduced vector yields and genetic instability.
Innovation Solution
A cell line expressing high levels of tetracycline repressor (TetR) under a cellular promoter is used to control transgene expression, preventing overexpression and maintaining stable TetR levels, thereby facilitating efficient adenoviral vector production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If strong promoters (e.g., HCMV promoter) are used to drive transgene expression in packaging cell lines, then high levels of antigenic protein expression is achieved, but virus replication is interfered with leading to reduced vector yields
Solution Approach 1:
The patent applies dynamic control of transgene expression through the tetracycline-responsive promoter system. The promoter can be switched between active and repressed states by adding or removing tetracycline, allowing the system to adapt expression levels to different production phases: high expression during vector production (with tetracycline) and low expression during virus replication (without tetracycline)
Solution Approach 2:
The patent changes the regulatory parameter of the promoter from constitutive (always active) to inducible (tetracycline-responsive). This parameter change allows control over when and how strongly the transgene is expressed, resolving the contradiction between needing high expression for antigen production and low expression for virus replication
2Quantity of substance
If strong promoters are used to drive transgene expression in packaging cell lines, then high levels of antigenic protein expression is achieved, but genetic instability of the vector occurs
Solution Approach 1:
The dynamic tetracycline-responsive system prevents genetic instability by allowing the promoter to be repressed during virus replication phases. This reduces selective pressure for rearranged vector species while maintaining the ability to achieve high expression when needed, thus preserving vector genetic stability
3Quantity of substance
If transgene over-expression is mediated in the packaging cell line, then high antigenic protein levels are produced, but detrimental effects on virus replication occur ranging from reduced yields to complete inhibition
Solution Approach 1:
The patent introduces tetracycline as an intermediary molecule that mediates between the promoter and the transgene. By controlling tetracycline presence, the system can intermediate between high expression (with tetracycline) and low expression (without tetracycline), preventing detrimental over-expression effects while maintaining production capability
Solution Approach 2:
The system changes the expression parameter from uncontrolled high level to controllable level through tetracycline addition. This parameter control ensures reliable virus replication by preventing over-expression toxicity while maintaining the capacity for high antigen production when required
Data Source
AI summary
The present invention relates to a cell line, use of the cell line and a method for producing infectious viral particles using said cell line.